Rituximab for treatment of severe renal disease in ANCA associated vasculitis

被引：0

作者：

Duvuru Geetha

Zdenka Hruskova

Marten Segelmark

Jonathan Hogan

Matthew D. Morgan

Teresa Cavero

Per Eriksson

Philip Seo

Rebecca L. Manno

Jessica Dale

Lorraine Harper

Vladimir Tesar

David RW Jayne

机构：

[1] Johns Hopkins University,Department of Medicine

[2] Charles University,Department of Nephrology

[3] Linkoping University,Department of Medicine

[4] Hospital of the University of Pennsylvania,Department of Medicine

[5] University of Birmingham,Department of Rheumatology

[6] Hospital 12 de Octubre in Madrid,Department of Clinical and Experimental Medicine

[7] Linköping University,School of Immunity and Infection, College of Medical and Dental Sciences

[8] Linköping University,Johns Hopkins Bayview Medical Center

[9] University of Birmingham,undefined

[10] Addenbrooke’s Hospital,undefined

[11] Johns Hopkins University,undefined

来源：

Journal of Nephrology | 2016年 / 29卷

关键词：

Rituximab; Renal disease; ANCA vasculitis;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：195 / 201

页数：6

共 71 条

[1]

Hogan SL(2005)Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis Ann Intern Med 143 621-631

[2]

Falk RJ(2007)Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis J Am Soc Nephrol 18 2180-2188

[3]

Chin H(2003)Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement Kidney Int 63 670-677

[4]

Cai J(2000)Longterm outcome of Wegener’s granulomatosis in patients with renal disease requiring dialysis J Rheumatol 27 1237-1240

[5]

Jennette CE(2003)Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study Am J Kidney Dis 41 776-784

[6]

Jennette JC(1992)Wegener granulomatosis: an analysis of 158 patients Ann Intern Med 116 488-498

[7]

Jayne DR(2015)Current therapy of granulomatosis with polyangiitis and microscopic polyangiitis: the role of rituximab J Nephrol. 28 17-27

[8]

Gaskin G(2014)Impact of rituximab trials on the treatment of ANCA-associated vasculitis Nephrol Dial Transplant 29 1151-1159

[9]

Rasmussen N(2012)The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines–application to the individual patient Kidney Int 82 840-856

[10]

Abramowicz D(2013)Rituximab for ANCA-associated vasculitis in the setting of severe infection Scand J Rheumatol 42 207-210

← 1 2 3 4 5 6 7 8 →